Skip to main content
GLUE filings

Corporate insider profile

Markus Warmuth Filing Activity

Latest reported as President & CEO of Monte Rosa Therapeutics, Inc. (GLUE).

Purchase filings
0
Reported companies
1
Net open-market value
-$571,042.95
Latest transaction
Jul 16, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jul 16, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale9,500$23.18$220,219
Jun 1, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale5,466$19.44$106,253
May 1, 2026Monte Rosa Therapeutics, Inc. (GLUE)President & CEOSale5,467$18.92$103,447